Vivelle-Dot

Novartis Pharmaceuticals Corporation🇺🇸 United States

FDA Page

Effective Date: Jul 11, 2022
Approval ID: e6f2e7ed-41a9-4a53-ac80-0cb1fa2edcbf
Products: 5 registered
Version: 14

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT (estradiol transdermal system) Initial U.S. Approval: 1996

Quick Stats

Total Products5

Labelers2

Label Sections25

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.